MedTrace Logo

LUMIERE on the FETUS

NCT04142606 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-11-20

No results posted yet for this study

Summary

Congenital anomalies are a major public health problem. They affect 2-3% of births, around 20,000 new cases per year in France, of which 15% are cared for in Ile de France. These congenital anomalies are a major cause of morbidity, infant mortality and disability. They are also a major cause of death during the infant period (22% of deaths during the first year of life: source CépiDC Inserm 2010). The detection, accurate diagnosis and accurate prognosis, particularly functional, of these congenital anomalies are still difficult in the current monitoring of pregnancy, which is based primarily on ultrasound. The use and development of modern imaging techniques is now essential to enable doctors to better see and better examine the fetus. Alongside ultrasound, Magnetic Resonance Imaging (MRI) is a technique that has undergone significant development in recent years. MRI must allow the effective anatomical and functional evaluation of the main fetal organs and could in particular be interesting in several situations in which it has not yet been sufficiently evaluated and is not yet performed in clinical routine.

Conditions

  • Pregnancy

Interventions

OTHER

fetal MRI

The MRI examination added by this research, without injection or sedation, induces no risk for the mother as for the fetus (s)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

  • LUMIERE Fondation ( fondation-lumiere.org) under the aegis of Fondation de France

    collaborator UNKNOWN

  • University of Paris 5 - Rene Descartes

    collaborator OTHER

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

Principal Investigators

  • Laurent Salomon, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-06
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04142606 on ClinicalTrials.gov